Haleon plc (HLN)
Price:
10.76 USD
( + 0.32 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Dr. Reddy's Laboratories Limited
VALUE SCORE:
8
2nd position
Bausch Health Companies Inc.
VALUE SCORE:
9
The best
Perrigo Company plc
VALUE SCORE:
10
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
NEWS
Haleon PLC Sponsored ADR (HLN) Moves to Buy: Rationale Behind the Upgrade
zacks.com
2026-02-26 13:00:53Haleon PLC Sponsored ADR (HLN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Haleon's weaker sales make mid-term targets 'not look credible'
proactiveinvestors.co.uk
2026-02-26 08:48:03Haleon PLC faces a familiar market dilemma after solid profit delivery was overshadowed by weaker than expected sales growth and cautious guidance. Fourth quarter organic growth of 2.1% disappointed, said Deutsche Bank, with misses in EMEA, Latin America and Asia Pacific, while North America was still down 1.0% like for like.
Haleon plc (HLN) Q4 2025 Earnings Call Prepared Remarks Transcript
seekingalpha.com
2026-02-25 14:07:49Haleon plc (HLN) Q4 2025 Earnings Call Prepared Remarks Transcript
Haleon plc (HLN) Q4 2025 Earnings Call Transcript
seekingalpha.com
2026-02-25 11:17:57Haleon plc (HLN) Q4 2025 Earnings Call Transcript
Haleon shares fall 3.4% as revenue growth falls short of the company's own medium-term target
proactiveinvestors.co.uk
2026-02-25 03:41:53A weak cold and flu season and a cautious American consumer pushed organic growth to 3%, a full percentage point below the floor of what Haleon has promised investors Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 3.4% to 392.1p on Wednesday after the consumer health group reported full-year organic revenue growth of 3%, missing the 4-6% medium-term range it has set as its benchmark and leaving investors to weigh whether the shortfall reflects bad luck or something more structural. Two factors drove the underperformance.
Haleon shares fall 3.4% as revenue growth falls short of the company's own medium-term target
proactiveinvestors.com
2026-02-25 03:38:00A weak cold and flu season and a cautious American consumer pushed organic growth to 3%, a full percentage point below the floor of what Haleon has promised...
AFC geared and ready for a pivotal year
proactiveinvestors.com
2026-02-25 02:56:00AFC Energy PLC (AIM:AFC, OTC:AFGYF, FRA:QC8) believes that 2026 will be the year its pipeline of hydrogen opportunities converts into contractual orders...
Haleon misses its own revenue target for the year as a mild winter and a cautious American consumer drag organic growth to 3%
proactiveinvestors.co.uk
2026-02-25 02:54:55The consumer health group behind Sensodyne and Panadol fell short of its 4-6% medium-term benchmark, but delivered double-digit profit growth and strong cash generation that management says keeps the longer-term case intact Haleon PLC (LSE:HLN, NYSE:HLN) ended 2025 below its own expectations on the measure that matters most to investors. Organic revenue growth of 3% for the full year came in a full percentage point below the floor of the 4-6% medium-term range the company set for itself, the result of two headwinds that converged in the second half and proved harder to offset than the business had anticipated.
UK's Haleon reports slower fourth-quarter organic revenue growth
reuters.com
2026-02-25 02:19:23British consumer healthcare group Haleon reported a slowdown in fourth‑quarter revenue growth on Wednesday, as a delayed flu season hit sales of its respiratory-health products.
Haleon plc (LON:HLN) Given Average Recommendation of “Moderate Buy” by Brokerages
defenseworld.net
2026-02-16 03:19:01Haleon plc (LON: HLN - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six brokerages that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on the company.
Cidel Asset Management Inc. Takes Position in Haleon PLC Sponsored ADR $HLN
defenseworld.net
2026-02-15 05:00:50Cidel Asset Management Inc. acquired a new position in Haleon PLC Sponsored ADR (NYSE: HLN) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 450,689 shares of the company's stock, valued at approximately $4,043,000. A number of other
ABC Arbitrage SA Increases Stake in Haleon PLC Sponsored ADR $HLN
defenseworld.net
2026-02-11 03:32:48ABC Arbitrage SA raised its holdings in shares of Haleon PLC Sponsored ADR (NYSE: HLN) by 159.4% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,727,350 shares of the company's stock after buying an additional 1,675,889 shares during the
New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief
businesswire.com
2026-02-10 10:01:00WARREN, N.J.--(BUSINESS WIRE)--The No. 1 dentist-recommended brand for sensitive teeth has launched Sensodyne Clinical Repair, its newest option for sensitive teeth, a toothpaste designed to address the root cause of tooth sensitivity. Based on data showing that 85% of people with sensitive teeth want solutions that repair sensitivity by addressing the root cause of their pain, Sensodyne developed Clinical Repair to go beyond temporary relief and actively repair sensitive areas of teeth with co.
Haleon PLC Sponsored ADR $HLN Shares Sold by Cambiar Investors LLC
defenseworld.net
2026-01-29 04:24:52Cambiar Investors LLC decreased its position in Haleon PLC Sponsored ADR (NYSE: HLN) by 94.9% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 66,003 shares of the company's stock after selling 1,229,351 shares during the period. Cambiar Investors LLC's
Haleon (NYSE:HLN) and Canopy Growth (NASDAQ:CGC) Head to Head Contrast
defenseworld.net
2026-01-29 01:28:58Canopy Growth (NASDAQ: CGC - Get Free Report) and Haleon (NYSE: HLN - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Canopy Growth and Haleon's net
Haleon PLC Sponsored ADR $HLN Shares Sold by Drive Wealth Management LLC
defenseworld.net
2026-01-26 04:12:43Drive Wealth Management LLC lowered its stake in shares of Haleon PLC Sponsored ADR (NYSE: HLN) by 85.5% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 10,808 shares of the company's stock after selling 63,709 shares during the period. Drive Wealth Management LLC's holdings
Haleon PLC Sponsored ADR (HLN) Moves to Buy: Rationale Behind the Upgrade
zacks.com
2026-02-26 13:00:53Haleon PLC Sponsored ADR (HLN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Haleon's weaker sales make mid-term targets 'not look credible'
proactiveinvestors.co.uk
2026-02-26 08:48:03Haleon PLC faces a familiar market dilemma after solid profit delivery was overshadowed by weaker than expected sales growth and cautious guidance. Fourth quarter organic growth of 2.1% disappointed, said Deutsche Bank, with misses in EMEA, Latin America and Asia Pacific, while North America was still down 1.0% like for like.
Haleon plc (HLN) Q4 2025 Earnings Call Prepared Remarks Transcript
seekingalpha.com
2026-02-25 14:07:49Haleon plc (HLN) Q4 2025 Earnings Call Prepared Remarks Transcript
Haleon plc (HLN) Q4 2025 Earnings Call Transcript
seekingalpha.com
2026-02-25 11:17:57Haleon plc (HLN) Q4 2025 Earnings Call Transcript
Haleon shares fall 3.4% as revenue growth falls short of the company's own medium-term target
proactiveinvestors.co.uk
2026-02-25 03:41:53A weak cold and flu season and a cautious American consumer pushed organic growth to 3%, a full percentage point below the floor of what Haleon has promised investors Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 3.4% to 392.1p on Wednesday after the consumer health group reported full-year organic revenue growth of 3%, missing the 4-6% medium-term range it has set as its benchmark and leaving investors to weigh whether the shortfall reflects bad luck or something more structural. Two factors drove the underperformance.
Haleon shares fall 3.4% as revenue growth falls short of the company's own medium-term target
proactiveinvestors.com
2026-02-25 03:38:00A weak cold and flu season and a cautious American consumer pushed organic growth to 3%, a full percentage point below the floor of what Haleon has promised...
AFC geared and ready for a pivotal year
proactiveinvestors.com
2026-02-25 02:56:00AFC Energy PLC (AIM:AFC, OTC:AFGYF, FRA:QC8) believes that 2026 will be the year its pipeline of hydrogen opportunities converts into contractual orders...
Haleon misses its own revenue target for the year as a mild winter and a cautious American consumer drag organic growth to 3%
proactiveinvestors.co.uk
2026-02-25 02:54:55The consumer health group behind Sensodyne and Panadol fell short of its 4-6% medium-term benchmark, but delivered double-digit profit growth and strong cash generation that management says keeps the longer-term case intact Haleon PLC (LSE:HLN, NYSE:HLN) ended 2025 below its own expectations on the measure that matters most to investors. Organic revenue growth of 3% for the full year came in a full percentage point below the floor of the 4-6% medium-term range the company set for itself, the result of two headwinds that converged in the second half and proved harder to offset than the business had anticipated.
UK's Haleon reports slower fourth-quarter organic revenue growth
reuters.com
2026-02-25 02:19:23British consumer healthcare group Haleon reported a slowdown in fourth‑quarter revenue growth on Wednesday, as a delayed flu season hit sales of its respiratory-health products.
Haleon plc (LON:HLN) Given Average Recommendation of “Moderate Buy” by Brokerages
defenseworld.net
2026-02-16 03:19:01Haleon plc (LON: HLN - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six brokerages that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on the company.
Cidel Asset Management Inc. Takes Position in Haleon PLC Sponsored ADR $HLN
defenseworld.net
2026-02-15 05:00:50Cidel Asset Management Inc. acquired a new position in Haleon PLC Sponsored ADR (NYSE: HLN) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 450,689 shares of the company's stock, valued at approximately $4,043,000. A number of other
ABC Arbitrage SA Increases Stake in Haleon PLC Sponsored ADR $HLN
defenseworld.net
2026-02-11 03:32:48ABC Arbitrage SA raised its holdings in shares of Haleon PLC Sponsored ADR (NYSE: HLN) by 159.4% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,727,350 shares of the company's stock after buying an additional 1,675,889 shares during the
New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief
businesswire.com
2026-02-10 10:01:00WARREN, N.J.--(BUSINESS WIRE)--The No. 1 dentist-recommended brand for sensitive teeth has launched Sensodyne Clinical Repair, its newest option for sensitive teeth, a toothpaste designed to address the root cause of tooth sensitivity. Based on data showing that 85% of people with sensitive teeth want solutions that repair sensitivity by addressing the root cause of their pain, Sensodyne developed Clinical Repair to go beyond temporary relief and actively repair sensitive areas of teeth with co.
Haleon PLC Sponsored ADR $HLN Shares Sold by Cambiar Investors LLC
defenseworld.net
2026-01-29 04:24:52Cambiar Investors LLC decreased its position in Haleon PLC Sponsored ADR (NYSE: HLN) by 94.9% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 66,003 shares of the company's stock after selling 1,229,351 shares during the period. Cambiar Investors LLC's
Haleon (NYSE:HLN) and Canopy Growth (NASDAQ:CGC) Head to Head Contrast
defenseworld.net
2026-01-29 01:28:58Canopy Growth (NASDAQ: CGC - Get Free Report) and Haleon (NYSE: HLN - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Canopy Growth and Haleon's net
Haleon PLC Sponsored ADR $HLN Shares Sold by Drive Wealth Management LLC
defenseworld.net
2026-01-26 04:12:43Drive Wealth Management LLC lowered its stake in shares of Haleon PLC Sponsored ADR (NYSE: HLN) by 85.5% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 10,808 shares of the company's stock after selling 63,709 shares during the period. Drive Wealth Management LLC's holdings